A Molecular Mechanism for Bacterial Susceptibility to Zinc

A neutrophil arrives at a site of infection and does something that looks almost mundane: it releases zinc. There is no targeted missile, no antibody handshake. Just metal, flooding the tissue. And somehow, that is enough to stop Streptococcus pneumoniae. The question is how. Streptococcus pneumoniae is the world's foremost bacterial pathogen, responsible for more than one million deaths annually, disproportionately affecting young children in developing countries. Zinc, chemically known as Zn(II), sits at the center of a paradox. It interacts with up to ten percent of all human proteins and is essential for immune function. Zinc deficiency affects nearly two billion people globally, and clinical trials have consistently linked supplementation to reduced rates of pneumonia. Yet, at elevated concentrations, zinc is toxic to bacteria. The host appears to mobilize it at mucosal surfaces during infection, leading to bacterial death. However, until the work by McDevitt and colleagues, the molecular reason remained unknown. The answer turns out to involve a case of mistaken identity at the bacterial surface. To understand it, you need to know about a protein called PsaA. PsaA is what’s known as a solute-binding protein — think of it as a molecular catcher's mitt. It floats just outside the bacterial cell, grabs manganese ions from the environment, and hands them to an importer called the psaBCA ABC transporter, which pulls manganese inside. Manganese is not optional for S. pneumoniae. It regulates diverse genes and is central to the bacterium's defense against oxidative stress — the kind of chemical assault that immune cells launch. Without manganese, the bacterium is exposed and vulnerable. McDevitt and colleagues quantified exactly how well PsaA binds metals using isothermal titration calorimetry, a technique that measures the heat released or absorbed when two molecules bind, allowing for precise calculation of affinity. The dissociation constant — the concentration at which half the binding sites are occupied, where a smaller value indicates tighter binding — came out at 3.3 nanomolar for manganese. That indicates high-affinity recognition. Zinc also binds PsaA, but its dissociation constant was 231 nanomolar, nearly two orders of magnitude weaker. On paper, that gap looks like a solid guarantee: PsaA should always prefer manganese. But the story does not end there. When the team solved high-resolution crystal structures of PsaA loaded with each metal, they found something striking. The structures were essentially identical. The same four amino acid side chains — histidine sixty-seven, histidine one hundred thirty-nine, glutamate two hundred five, and aspartate two hundred eighty — coordinate the metal in the same tetrahedral geometry, whether the metal is manganese or zinc. When the two structures were overlaid, the root-mean-square deviation for the protein backbone was just 0.50 angstroms. The only local difference was a thirty-one degree rotation of one histidine ring to accommodate manganese's slightly larger atomic volume, and even that did not change the distance between the metal and its ligand. The protein cannot distinguish the two metals by shape. The binding pocket looks the same either way. This is where thermal stability data become key. The team used a thermal-shift assay — heating the protein and watching when it unfolds — and found a dramatic difference. Manganese-bound PsaA unfolded at sixty-five point one degrees Celsius, while zinc-bound PsaA held its structure all the way to seventy-two point nine degrees Celsius. That nearly eight-degree gap is functionally significant. It means the zinc-bound form is far more stable and much harder to dislodge. When the researchers tried to displace zinc from PsaA using excess manganese, they couldn't. The zinc-PsaA complex was resistant to dialysis, to chelators, and to competition. Once zinc locks in, the protein is stuck. The authors call it a dead-end complex. Here is the trap. Zinc binds PsaA less eagerly than manganese does in equilibrium terms — those two-order-of-magnitude numbers are real — but when zinc does bind, it holds on with a grip that manganese cannot break. The protein becomes irreversibly occupied. The gate stays shut. The bacteria feel it immediately. When McDevitt and colleagues grew S. pneumoniae at progressively higher ratios of extracellular zinc to manganese, the bacteria slowed down and then stopped. At a ratio of one thousand to one, growth was completely inhibited. More tellingly, they measured what was actually happening inside the cells using inductively coupled plasma mass spectrometry — a technique that quantifies trace metals in biological tissue with high precision. At a zinc-to-manganese ratio of one hundred to one, intracellular manganese fell by roughly five-fold compared to bacteria grown at lower ratios, with a p-value of zero point zero zero two. Intracellular zinc, by contrast, did not show a corresponding toxic spike. The bacteria were not drowning in zinc; they were starving for manganese. The team confirmed this using a deletion mutant — a strain of S. pneumoniae engineered to have no PsaA at all. That mutant grows poorly, regardless of external metal conditions, because it simply cannot import manganese. Here is the telling comparison: bacteria grown at competitive zinc-to-manganese ratios showed the same phenotype as that deletion mutant. They exhibited the same intracellular metal profile and the same growth impairment. Zinc, by locking PsaA, effectively recreates the biology of a strain missing the entire manganese importer. The downstream consequences are severe. Manganese-starved bacteria become hypersensitive to oxidative stress. In assays using paraquat — a compound that generates reactive oxygen species — manganese-replete wild-type bacteria survived at one hundred percent by definition. Wild-type bacteria grown at a one hundred to one zinc-to-manganese ratio survived at only thirty-one percent. The deletion mutant survived at eighteen percent. The manganese-starved bacteria also died more readily when exposed to neutrophils: in PMN killing assays, manganese-replete wild-type survived at twenty-two percent, zinc-exposed wild-type at thirteen percent, and the deletion mutant at five percent. Each step in that chain — zinc blocks PsaA, manganese can't get in, oxidative defenses collapse, and immune killing becomes efficient — is supported by discrete measurements. The final piece is whether any of this happens in a living animal. McDevitt and colleagues infected mice with S. pneumoniae and, forty-eight hours later, measured metal concentrations in tissues using inductively coupled plasma mass spectrometry. In uninfected mice, the zinc-to-manganese ratio across relevant sites ranged from about thirty-three to one in brain tissue to sixty-three to one in the nasopharynx. After infection, zinc concentrations rose sharply in every tissue while manganese stayed largely unchanged. The nasopharynx ratio climbed to roughly three hundred thirty to one — a statistically significant five-fold increase, with a p-value of zero point zero one six three. Blood serum reached nearly nine hundred to one, a twenty-four fold jump, with a p-value of zero point zero two nine two. Those are not modest fluctuations, and they land squarely in the range that the in vitro experiments showed is sufficient to impair manganese uptake, induce starvation, and sensitize bacteria to killing. The host is not doing something exotic. It is doing exactly what the molecular data predicted. Zinc rises, manganese stays put, PsaA gets locked, and the bacteria run short of the one metal they most need to survive immune assault. What emerges from this work is a molecular account of something immunologists call nutritional immunity — the host's strategy of withholding or weaponizing essential nutrients against pathogens. Iron sequestration is the classic example, known for decades. McDevitt and colleagues have now shown that zinc can serve the same function through a different mechanism: not sequestration, but competitive displacement at the surface of the bacterium itself. Zinc does not need to get inside the cell to do damage. It just needs to bind PsaA and refuse to let go. This also offers a molecular explanation for clinical data that, until now, had a biological connection but no mechanism: the link between dietary zinc deficiency and susceptibility to pneumococcal pneumonia. If the host cannot raise tissue zinc concentrations during infection, the competitive pressure on PsaA never builds, manganese continues flowing in, and the bacterium retains its oxidative armor. Finally, proteins similar to PsaA — what the authors call Cluster A-1 solute-binding proteins — are found across other major pathogens, including Yersinia pestis, Staphylococcus aureus, and Streptococcus pyogenes. The mechanism described here may not be specific to one species. Zinc at mucosal surfaces, it turns out, is a very old trick. We are only now reading the instruction manual. This lecture was created by ennepō. Go to https://ennepo.ai to Discover, Create and Follow the latest research in your field. Read when you can. Listen when you want to.